Skip to main content

Frequency of Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) and Estimated Incidence Rates of Post-PTSMA Cardiovascular Outcomes: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Health Outcome(s)
percutaneous transluminal septal myocardial ablation
Description

The goal of this request was to identify and count percutaneous transluminal septal myocardial ablation (PTSMA) procedures, and estimate incidence rates of post-PTSMA cardiovascular outcomes in the Sentinel Distributed Database (SDD). Only aggregate level data was returned. Two runs of the program were required.

The study period included data from June 1, 2014 to June 21, 2018. We distributed this request to 16 Data Partners on October 28, 2019.

Deliverables (1)
Sentinel Modular Program Report: Frequency of Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) and Estimated Incidence Rates of Post-PTSMA Cardiovascular Outcomes: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
June 1, 2014 - June 21, 2018
Analysis Type
Descriptive
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Ablysinol (Dehydrated Alcohol) & Atrioventricular Block, Heart Failure, Myocardial Infarction, Permanent Pacemaker Placement, Septal Myectomy, and Ventricular Arrhythmia